These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 8618580

  • 1. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Häussinger D.
    N Engl J Med; 1996 May 30; 334(22):1422-7. PubMed ID: 8618580
    [Abstract] [Full Text] [Related]

  • 2. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients.
    Ma H, Yang RF, Wei L.
    J Gastroenterol Hepatol; 2010 Sep 30; 25(9):1498-506. PubMed ID: 20796146
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
    Teuber G, Dienes HP, Meyer Zum Büschenfelde KH, Gerken G.
    Z Gastroenterol; 1996 Apr 30; 34(4):230-6. PubMed ID: 8686350
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 30; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 5. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM.
    Am J Gastroenterol; 1996 Nov 30; 91(11):2323-8. PubMed ID: 8931411
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM, Fong TL, Fried MW, Swain MG, Baker B, Korenman J, Bergasa NV, Waggoner JG, Park Y, Hoofnagle JH.
    Am J Gastroenterol; 1993 Nov 30; 88(11):1887-92. PubMed ID: 8237937
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW.
    Hepatology; 1997 Nov 30; 26(5):1338-42. PubMed ID: 9362381
    [Abstract] [Full Text] [Related]

  • 8. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P, Del Ninno E, Manzin A, Donato MF, Rumi MG, Lunghi G, Morabito A, Clementi M, Colombo M.
    Hepatology; 1997 Dec 30; 26(6):1621-5. PubMed ID: 9398007
    [Abstract] [Full Text] [Related]

  • 9. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
    Carreño V, Marcellin P, Hadziyannis S, Salmerón J, Diago M, Kitis GE, Vafiadis I, Schalm SW, Zahm F, Manzarbeitia F, Jiménez FJ, Quiroga JA.
    Hepatology; 1999 Jul 30; 30(1):277-82. PubMed ID: 10385667
    [Abstract] [Full Text] [Related]

  • 10. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
    Kanai K, Kako M, Aikawa T, Hino K, Tsubouchi H, Takehira Y, Iwabuchi S, Kawasaki T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M.
    Am J Gastroenterol; 1996 Oct 30; 91(10):2150-6. PubMed ID: 8855739
    [Abstract] [Full Text] [Related]

  • 11. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G, Pillan MN, Lepore L, Parrella T.
    Hepatology; 1994 Aug 30; 20(2):287-90. PubMed ID: 8045488
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R, Cinar K, Seven G, Bozkus Y, Elhan A, Bozdayi M, Yurdaydin C, Bahar K.
    J Viral Hepat; 2012 Mar 30; 19(3):220-6. PubMed ID: 22329377
    [Abstract] [Full Text] [Related]

  • 13. Management of chronic hepatitis B.
    Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.
    Evid Rep Technol Assess (Full Rep); 2008 Oct 30; (174):1-671. PubMed ID: 19408969
    [Abstract] [Full Text] [Related]

  • 14. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
    Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, Dauvergne A, Cardoso AC, Asselah T, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P.
    J Hepatol; 2009 Jun 30; 50(6):1084-92. PubMed ID: 19376603
    [Abstract] [Full Text] [Related]

  • 15. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ, Fang F, Guo ZF, Chen Q.
    Zhonghua Er Ke Za Zhi; 2007 Aug 30; 45(8):592-8. PubMed ID: 18021533
    [Abstract] [Full Text] [Related]

  • 16. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH.
    Ann Intern Med; 1991 Apr 15; 114(8):629-34. PubMed ID: 2003708
    [Abstract] [Full Text] [Related]

  • 17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM, Bilous M, Williams SJ, Farrell GC.
    Med J Aust; 1995 Jan 02; 162(1):8-11. PubMed ID: 7845310
    [Abstract] [Full Text] [Related]

  • 18. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM, Wirth S, Goyens P, Depreterre A, Cornu C.
    Gut; 1993 Jan 02; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [Abstract] [Full Text] [Related]

  • 19. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zignego L, Papaioannou C.
    J Hepatol; 1990 Jan 02; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.
    Hepatology; 2004 Mar 02; 39(3):804-10. PubMed ID: 14999700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.